• 2010

Company Description

Commercialize disruptive diagnostic technologies to aid in diagnosis and treatment of diseases of women and children.

They develop high-value proteomics-based diagnostic tests. They acquire promising new proteomic research in partnership with leading academic and medical research institutions, and thru clinical research and commercial partnerships, validate and bring these new tests to market.